New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2014
08:47 EDTTEVA, BBRY, DISH, MSFT, ORCL, UBS, BRCM, DRI, GE, INTC, LVS, PFE, HPQ, FOn the Fly: Periodicals Wrap
WSJ: Las Vegas Sands' (LVS) Adelson: 'I'd spend $10B in Japan'... Starboard wants Red Lobster spinoff vote by Darden (DRI) shareholders...HP's (HPQ) Whitman: 'Hardware increasingly being pivoted to software'...Chip makers (INTC, BRCM) race to offer faster mobile networks...Pfizer (PFE) to again ship thyroid drug Levoxyl following recall...REUTERS: GE (GE) to increase energy research $10B by 2020...BLOOMBERG: Ford (F) to dump Microsoft (MSFT) for BlackBerry (BBRY) in next-generation Sync...UBS (UBS) wants immunity from U.S., EU in fx investigations...LightSquared says Dish's (DISH) Ergen can agree to plan or risk $1B...Teva (TEVA) advances amidst takeover speculation...OTHER NEWS: Oracle (ORCL) close to buying BlueKai for about $400M, Business Insider reports.
News For LVS;DRI;HPQ;INTC;BRCM;PFE;GE;F;MSFT;BBRY;UBS;DISH;TEVA;ORCL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
February 17, 2015
08:35 EDTTEVATeva announces launch of generic Lovenox and Zyvox in U.S.
Subscribe for More Information
07:30 EDTUBSFrance requests testimony of UBS U.S. whistleblower, WSJ says
Subscribe for More Information
07:22 EDTINTCMitsubishi UFJ to hold a tour
Subscribe for More Information
07:04 EDTTEVATeva, Eagle enter license agreement for EP-3102
Teva Pharmaceutical Industries (TEVA) and Eagle Pharmaceuticals (EGRX) announce that the companies have entered into an exclusive license agreement for EP-3102, Eagle’s bendamustine hydrochloride rapid infusion product for the treatment of chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma. Teva will be responsible for all U.S. commercial activities for the product including promotion and distribution. Eagle has responsibility for obtaining all regulatory approvals, conducting post-approval clinical studies, if required, and initially supplying drug product to Teva. As part of the agreement, Teva will waive its orphan drug exclusivities for NHL and CLL with respect to EP-3102, which should allow the product to come to market more quickly. Under the terms of the exclusive license agreement, Eagle will receive an upfront cash payment of $30M and is eligible to receive up to $90M in additional milestone payments. In addition, Eagle will receive double-digit royalties on net sales of the product, assuming FDA approval. The companies will also settle the pending patent infringement action between them.
06:39 EDTUBSBanks settle claims related to mortgage securities, Reuters says
Subscribe for More Information
06:15 EDTDISHCiti sees three options for DISH, including sale to Verizon
Subscribe for More Information
06:05 EDTFFord recalls 17,875 Falcons and Territories in Australia
Subscribe for More Information
05:55 EDTINTCIntel to delay launch of 14nm Skylake desktop CPUs, DigiTimes reports
Subscribe for More Information
05:51 EDTMSFTStocks with implied volatility below IV index mean; MSFT QCOM
Subscribe for More Information
February 16, 2015
17:24 EDTORCLFIS, Oracle among those exploring Monitise bid, Sky News reports
FIS (FIS) is among the U.S. companies considering a takeover bid for Monitise, the UK mobile banking software manufacturer which put itself up for sale last month, Mark Kleinman of Sky News reports. Other possible bidders include Oracle (ORCL) and IBM (IBM), Kleinman added. He pointed out that all of the takeover discussions are said to be at an early stage. Reference Link
February 15, 2015
15:42 EDTGEGE inaugurates new Indian manufacturing facility, Reuters says
General Electric inaugurated its new manufacturing facility in India this weekend that the conglomerate will use as an export hub, with plans to send half of its output to the company's global factories, says Reuters. The new Indian facility will be a major part of GE's plan to win increased domestic orders there, added Reuters. Reference Link
February 13, 2015
17:40 EDTHPQRelational Investors gives quarterly update on stakes
Subscribe for More Information
10:28 EDTPFEPfizer announces FDA acceptance for review of NDA for ALO-02
Subscribe for More Information
09:35 EDTBBRYBlackBerry mentioned positively at Cleveland Research
Subscribe for More Information
09:25 EDTMSFTUBS software analyst to hold an analyst/industry conference call
Software Analyst Thill, along with Microsoft expert, author and blogger Mary Jo Foley, discuss Microsoft and whether the commercial slowdown is permanent, with AWS (Amazon Web Services) dropping prices and Microsoft matching, how will they make money in the cloud on an Analyst/Industry conference call to be held on February 13 at 11 am.
08:23 EDTTEVAPiper Jaffray biotech/healthcare analysts hold analyst/industry conference call
Subscribe for More Information
08:19 EDTPFEAckman noncommittal on McDonald's rumors, Bloomberg reports
Subscribe for More Information
07:05 EDTMSFTMicrosoft volatility at historic lows
Subscribe for More Information
06:01 EDTHPQHP volatility elevated into Q1 and growth outlook
HP February call option implied volatility is at 23, March is 30, April is at 28, August is at 27; compared to its 26-week average of 27 according to Track Data, suggesting large near term price movement into the expected release of Q1 results on February 24.
05:45 EDTMSFTStocks with implied volatility below IV index mean; MSFT QCOM
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use